Literature DB >> 33590389

Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients.

Tomohide Tanabe1, Mai Koeda1, Yuichi Kitasako2,3, Eri Momma1, Yoshimasa Hoshikawa1, Shintaro Hoshino1, Noriyuki Kawami1, Mitsuru Kaise1, Katsuhiko Iwakiri4.   

Abstract

BACKGROUND: Salivary secretion in patients with proton-pump inhibitor (PPI)-resistant severe reflux esophagitis has not been examined. In this study, saliva secretion and salivary epidermal growth factor (EGF) in patients with PPI-resistant severe reflux esophagitis were investigated.
METHODS: We recruited 22 PPI-resistant and 22 PPI-responsive severe reflux esophagitis patients who were not infected with Helicobacter pylori. Saliva secretion testing and esophageal manometry using high-resolution manometry were performed. Saliva secretion was assessed as follows: each patient chewed sugar-free gum for 3 min prior to endoscopy and the amount and pH of saliva as well as the pH of saliva after acid loading as an index of the acid-buffering capacity were measured. The salivary EGF concentration was assessed by ELISA.
RESULTS: The amount of saliva secreted was significantly lower in the PPI-resistant group than in the PPI-responsive group, with medians (25th-75th percentile) of 3.7 (2.2-6.8) and 4.9 (4.0-7.8) mL, respectively (p = 0.029). Salivary pH was significantly lower in the PPI-resistant group [6.9 (6.7-7.2)] than in the PPI-responsive group [7.2 (7.1-7.4), p = 0.001]. Salivary pH after acid loading was significantly lower in the PPI-resistant group [5.6 (5.3-5.9)] than in the PPI-responsive group [6.4 (6.1-6.5), p = 0.002]. The salivary EGF concentration was significantly higher in the PPI-resistant group [3211.5 (1865.0-4121.5)] than in the PPI-responsive group [1816.0 (1123.5-2792.3), p = 0.041]. No significant differences were observed in the proportion of esophageal motility abnormalities.
CONCLUSION: Stimulated saliva secretion was reduced in PPI-resistant severe reflux esophagitis patients.

Entities:  

Keywords:  PPI-resistant reflux esophagitis; Saliva secretion; Salivary epidermal growth factor; Severe reflux esophagitis

Mesh:

Substances:

Year:  2021        PMID: 33590389     DOI: 10.1007/s10388-021-00825-1

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  37 in total

1.  Relationship between severity of reflux esophagitis according to the Los Angeles classification and esophageal motility.

Authors:  T Sugiura; K Iwakiri; M Kotoyori; M Kobayashi
Journal:  J Gastroenterol       Date:  2001-04       Impact factor: 7.527

2.  Effect of peristaltic dysfunction on esophageal volume clearance.

Authors:  P J Kahrilas; W J Dodds; W J Hogan
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 3.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

4.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Authors:  Takahisa Furuta; Tomohiko Shimatani; Mitsushige Sugimoto; Shunji Ishihara; Yasuhiro Fujiwara; Motoyasu Kusano; Tomoyuki Koike; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

5.  Determinants of esophageal acid clearance in normal subjects.

Authors:  J F Helm; W J Dodds; D R Riedel; B C Teeter; W J Hogan; R C Arndorfer
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

6.  Evidence for decreased salivary function in patients with reflux esophagitis.

Authors:  C H Kao; Y J Ho; S P ChangLai; K K Liao
Journal:  Digestion       Date:  1999       Impact factor: 3.216

7.  Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification.

Authors:  L R Lundell; J Dent; J R Bennett; A L Blum; D Armstrong; J P Galmiche; F Johnson; M Hongo; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

8.  Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in Japan.

Authors:  Kazuma Fujimoto; Michio Hongo
Journal:  J Gastroenterol       Date:  2010-07-06       Impact factor: 7.527

9.  Esophageal peristaltic dysfunction in peptic esophagitis.

Authors:  P J Kahrilas; W J Dodds; W J Hogan; M Kern; R C Arndorfer; A Reece
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

10.  Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan.

Authors:  Hideki Mizuno; Nobuyuki Matsuhashi; Masahiro Sakaguchi; Syuji Inoue; Koji Nakada; Kazuhide Higuchi; Ken Haruma; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2015-10-07       Impact factor: 3.114

View more
  1 in total

1.  Comparative Study of Salivary pH, Buffer Capacity, and Flow in Patients with and without Gastroesophageal Reflux Disease.

Authors:  Farah Bechir; Mariana Pacurar; Adrian Tohati; Simona Maria Bataga
Journal:  Int J Environ Res Public Health       Date:  2021-12-25       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.